SafeRide Health (SRH) is the new provider for all NEMT rides to doctor appointments and pharmacy visits.
Depending on your needs, rides may include wheelchair-lift-equipped vehicles, stretcher vans, minivans, or ambulatory vans. Please let SRH know what type of ride you need when scheduling.
SafeRide Health (SRH) es el nuevo proveedor de todos los servicios de transporte médico que no son de emergencia (NEMT, por sus siglas en inglés) hacia consultas médicas y farmacias.
Según tus necesidades, los servicios de transporte pueden incluir vehículos con elevador para sillas de ruedas, camionetas con camilla, minivans o camionetas ambulatorias. Por favor, informa a SRH qué tipo de transporte necesitas al programar tu traslado.
Providers should monitor the Texas Children’s Health Plan (TCHP) Provider Portal regularly for alerts and updates associated to the COVID-19 event. TCHP reserves the right to update and/or change this information without prior notice due to the evolving nature of the COVID-19 event.
Call to action: Beginning with the 2022-23 Human Respiratory Syncytial Virus (RSV) season, the Texas Health and Human Services Commission (HHSC) implemented simplified approval criteria for Synagis subsequent dosing (renewals). Pharmacies will no longer be required to coordinate with providers’ offices for subsequent refill authorizations.
How this impacts providers There are no immediate changes for providers. Members will only require one prior authorization approval for Synagis prophylaxis and may apply it to up to five monthly doses per treatment course.
However, providers should be aware that subsequent refills will be denied if the member experiences breakthrough RSV hospitalization. Providers should notify Texas Children’s Health Plan and the dispensing pharmacy if members are hospitalized.
Next steps for providers: Providers should share this communication with their staff. The Synagis Prior Authorization Addendum for Medicaid (HHSC Form 1321) is available for reference.
